Researchers from the University of Georgia (GA, USA) have suggested the cause behind an increase in breast cancer genetic testing in the US in 2013.
Browsing: BRCA mutations
Increase in numbers of women tested for BRCA mutations, however, some high-risk women still remain unidentified
Research suggests that detection of BRCA mutation carriers is still not being maximized, despite more and more women being tested.
To mark Triple-Negative Breast Cancer Day, take a look at our new and exclusive summary infographic presenting some of the key facts about triple-negative breast cancer.
New study indicates that women carrying the BRCA gene mutation may be at increased risk of developing a lethal form of uterine cancer.
Researchers at the University of Birmingham (UK) have suggested that BRCA1 may have several roles in DNA repair, indicating new avenues for future treatments against breast cancer.
This review discusses familial breast cancer susceptibility, the aims, logistics and vision of the 100,000 Genomes Project and how patients were recruited to the project.
This article covers various genetic testing strategies for gynecological cancers, including population-based approaches, panel and direct-to-consumer testing as well as the need for innovative approaches to genetic counseling.
NICE have issued guidance to the NHS recommending the PARP inhibitor olaparib for the treatment of BRCA-mutated ovarian cancer in England.
Preclinical study hints at synergistic effect of PARP inhibitors in combination with inhibitors of c-MET in breast cancer and potentially other tumor types.
Learn further about the factors that are considered when a women at higher risk of cancer decides whether to use oral contraceptive pills.